Antifungal testing and high-throughput screening of compound library against geomyces destructans, the etiologic agent of geomycosis (WNS) in bats

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Chaturvedi, Sudha ^a,b   Rajkumar, Sunanda S ^a   Li, Xiaojiang ^a   Hurteau, Gregory J ^c   Shtutman, Michael ^c   Chaturvedi, Vishnu ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c ORDWAY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; BIOCIDE; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; FUNGAL STRAIN; FUNGUS; FUNGUS GROWTH; GEOMYCES DESTRUCTANS; GROWTH INHIBITION; HIGH THROUGHPUT SCREENING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ANIMAL; ASCOMYCETES; BAT; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR LIBRARY; MYCOSIS;

FUNGI; GEOMYCES; MYOTIS LUCIFUGUS;

ANIMALS; ANTIFUNGAL AGENTS; ASCOMYCOTA; CHIROPTERA; HIGH-THROUGHPUT SCREENING ASSAYS; MICROBIAL SENSITIVITY TESTS; MYCOSES; SMALL MOLECULE LIBRARIES;

EID: 79952306909     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017032     Document Type: Article

References (30)

1. Blehert DS, Hicks AC, Behr M, Meteyer CU, Berlowski-Zier BM, et al. (2009) Bat white-nose syndrome: an emerging fungal pathogen? Science 323: 227.
2. Chaturvedi V, Springer DJ, Behr MJ, Ramani R, Li X, et al. (2010) Morphological and molecular characterizations of psychrophilic fungus Geomyces destructans from New York bats with White Nose Syndrome (WNS). PLoS One 5: e10783.
3. Frick WF, Pollock JF, Hicks AC, Langwig KE, Reynolds DS, et al. (2010) An emerging disease causes regional population collapse of a common North American bat species. Science 329: 679-682.
4. Voyles J, Young S, Berger L, Campbell C, Voyles WF, et al. (2009) Pathogenesis of chytridiomycosis, a cause of catastrophic amphibian declines. Science 326: 582-585.
5. Garner TWJ, Garcia G, Carroll B, Fisher MC, (2009) Using itraconazole to clear Batrachochytrium dendrobatidis infection, and subsequent depigmentation of Alytes muletensis tadpoles. Dis Aqua Org 83: 257-260.
6. Tamukai K, Une Y, Tominaga A, Suzuki K, Goka K, (2010) Treatment of spontaneous chytridiomycosis in captive amphibians using itraconazole. J Vet Med Sci.
7. Berger L, Speare R, Marantelli G, Skerratt LF, (2009) A zoospore inhibition technique to evaluate the activity of antifungal compounds against Batrachochytrium dendrobatidis and unsuccessful treatment of experimentally infected green tree frogs (Litoria caerulea) by fluconazole and benzalkonium chloride. Res Vet Sci 87: 106-110.
8. Martel A, Rooij PV, Vercauteren G, Baert K, Waeyenberghe LV, et al. (2010) Developing a safe antifungal treatment protocol to eliminate Batrachochytrium dendrobatidis from amphibians. Med Mycol doi:10.3109/13693786.2010.508185.
9. Shapiro J, Pringle A, (2009) Anthropogenic influences on the diversity of fungi isolated from caves in Kentucky and Tennessee. Am Mdl Nat 163: 76-86.
10. Cunningham KI, Northup DE, Pollastro RM, Wright WG, LaRock EJ, (1995) Bacteria, fungi and biokarst in Lechuguilla Cave, Carlsbad Caverns National Park, New Mexico. Environmental Geology 25: 2-8.
11. CLSI (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. M27-A3. Vol. 28 No. 14 Wayne, PA Clinical Laboratory Standards Institute.
12. CLSI (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard- Second Edition. M38-A2. Vol. 28. No. 16 Wayne, PA Clinical and Laboratory Standards Institute.
13. Espinel-Ingroff A, (2003) In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev Iberoam Micol 20: 121-136.
14. Wagner GE, Shadomy S, (1979) Studies on the mode of action of 5-fluorocytosine in Aspergillus species. Chemotherapy 25: 61-69.
15. Arikan S, Lozano-Chiu M, Paetznick V, Rex JH, (2001) In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother 45: 327-330.
16. Katiyar SK, Edlind TD, (2009) Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae. Antimicrob Agents Chemother 53: 1772-1778.
17. Zhang L, Yan K, Zhang Y, Huang R, Bian J, et al. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. PNAS 104: 4606-4611.
18. Okoli I, Coleman JJ, Tampakakis E, An WF, Holson E, et al. (2009) Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS One 4: e7025.
19. Polak A, (1983) Mode of action of 5-fluorocytosine and 5-fluorouracil in dematiaceous fungi. Sabouraudia 21: 15-25.
20. Hoskins J, Scott Butler J, (2007) Evidence for distinct DNA- and RNA-based mechanisms of 5-fluorouracil cytotoxicity in Saccharomyces cerevisiae. Yeast 24: 861-870.
21. Tosh FE, Weeks RJ, Pfeiffer FR, Hendricks SL, Chin TDY, (1966) Chemical decontamination of soil containing Histoplasma capsulatum. Am J Epidemiol 83: 262-270.
22. Urzì C, De Leo F, Bruno L, Albertano P, (2010) Microbial diversity in Paleolithic Caves: A study case on the phototrophic biofilms of the Cave of Bats (Zuheros, Spain). Microb Ecol 60: 116-129.
23. Marchetti V, Mancianti F, Cardini G, Luchetti E, (2006) Evaluation of fungicidal efficacy of benzalkonium chloride (Steramina G uv) and Virkon-S against Microsporum canis for environmental disinfection. Vet Res Commun 30: 255-261.
24. Bastian F, Alabouvette C, Jurado V, Saiz-Jimenez C, (2009) Impact of biocide treatments on the bacterial communities of the Lascaux Cave. Naturwissenschaften 96: 863-868.
25. Bending GD, Rodríguez-Cruz MS, Lincoln SD, (2007) Fungicide impacts on microbial communities in soils with contrasting management histories. Chemosphere 69: 82-88.
26. Maltby L, Brock TCM, van den Brink PJ, (2009) Fungicide risk assessment for aquatic ecosystems: Importance of interspecific variation, toxic mode of action, and exposure regime. Environ Sci Technol 43: 7556-7563.
27. Martin-Mazuelos E, Peman J, Valverde A, Chaves M, Serrano MC, et al. (2003) Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. J Antimicrob Chemother 52: 365-370.
28. Martos A, Romero A, Gonzalez MT, Gonzalez A, Serrano C, et al. (2010) Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins. Med Mycol 48: 858-861.
29. EUCAST (2008) EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds Clin Microbiol Infect: Blackwell Publishing Ltd pp. 982-984.
30. Li H, Black PN, Chokshi A, Sandoval-Alvarez A, Vatsyayan R, et al. (2008) High-throughput screening for fatty acid uptake inhibitors in humanized yeast identifies atypical antipsychotic drugs that cause dyslipidemias. J Lipid Res 49: 230-244.